课题基金 / 基金详情

Biomechanical Activation of Yap Induces Hematopoietic Stem Cell Production

Biomechanical Activation of Yap Induces Hematopoietic Stem Cell Production
Yap 的生物力学激活诱导造血干细胞产生
批准号:
10596562
负责人:
TRISTA E. NORTH
金额:
$53.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-04-01 至 2025-03-31
关键词:
AdultAortaBiomechanicsBiomimeticsBiophysicsBloodBlood VesselsBlood flowCell CountCell Differentiation processCellsChemicalsClinicClinicalClinical ProtocolsCuesDataDevelopmentDorsalEmbryoEmbryonic DevelopmentEndotheliumEngraftmentFoundationsGeneticGenetic EpistasisGenetic TranscriptionGoalsHarvestHematological DiseaseHematologyHematopoieticHematopoietic Cell ProductionHematopoietic NeoplasmsHematopoietic Stem Cell SpecificationHematopoietic Stem Cell TransplantationHematopoietic SystemHematopoietic stem cellsHumanImmuneImmune systemImmunocompromised HostIn VitroMechanicsMediatingMicrofluidic MicrochipsMicrofluidicsMicroscopyMolecularMusNitric OxideNuclearOrganismPathway interactionsPopulationProcessProductionProductivityProtocols documentationRUNX1 geneRegulationReportingResearchRoleSignal PathwaySignal TransductionSiteSpecific qualifier valueStem Cell DevelopmentStressStretchingSystemTherapeuticTherapeutic UsesTranscriptional ActivationTranscriptional RegulationTransplantationVascular EndotheliumVascular remodelingVertebratesWorkZebrafishcell typechemical geneticscurative treatmentsembryo circulationexperimental studygene regulatory networkhematopoietic stem cell fatehematopoietic stem cell formationhemogenic endotheliumin vitro activityin vivoinduced pluripotent stem cellinnovationintravital microscopymechanical forcemechanical propertiesmechanotransductionnovelprogramsrhorho GTP-Binding Proteinsself-renewalshear stressstandard of carestem cell functionstem cellsstem-like cellsuccesstranscription factortranslational impactvertebrate embryos

项目摘要

项目成果

TRISTA E. NORTH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SUMMARY Hematopoietic stem cells (HSCs), first produced in the developing vertebrate embryo, supply the lifelong foundation of the blood and immune systems. HSCs are therapeutically valuable as HSC transplantation (HSCT), the administration of donor HSCs to an immunocompromised recipient, is the standard of care for many hematological diseases. However, treatment availability remains problematic due to immune incompatibility and donor shortage. Likewise, while the number of transplanted HSCs is well known to directly impact engraftment efficiency, there are currently no established clinical protocols to successfully expand donor-harvested HSCs, nor to differentiate embryonic or induced pluripotent stem cells (iPSCs) into functional HSCs in vitro. Therefore, the identification of novel modifiers of de novo production of HSCs with long-term self-renewal and differentiation capacity is a major unmet clinical need. Despite more than a decade of research, current protocols rely primarily on enforced expression of transcription factors to help steer cells into an “HSC-like” transcriptional program, however transplantation of these in vitro-derived HSCs into irradiated mice illustrates both limited long-term engraftment and multilineage potential. These observations imply that current in vitro differentiation strategies are missing critical cues which are essential to unlock or maintain full HSC potential in vivo. In the developing embryo, definitive HSCs arise from a unique population of mesodermal precursors termed hemogenic endothelium (HEC) through a process known as endothelial-to-hematopoietic transition (EHT). The transcription factor RUNX1, expressed in all sites of de novo HSC formation across vertebrates, is required for HSC specification and EHT. Our prior work revealed that Runx1 expression is strongly upregulated after initiation of the embryonic heartbeat, and HSC production is coordinated with the onset of vigorous circulatory flow and sheer stress. While mechanical properties of the niche, including sheer stress and circumferential stretch, are increasingly recognized as important stem cell cues in many contexts, the mechanism(s) by which mechanotransduction drives commitment to hemogenic fate and HSC productionduring vertebrate development remain largely unexplored. This study aims to characterize the role of biomechanical modulation of the hemogenic vascular niche in HSC formation in vivo and in vitro, with the overall goal of identifying the signaling pathway(s) connecting select biophysical forces to the gene regulatory network controlling HSC commitment. Our preliminary data indicate a novel, yet essential, role for circumferential stretch- stimulated activation of the transcription factor Yap1 in regulation of Runx1+ HEC specification and HSC production. Defining the molecular signaling pathways that mediate productive HSC formation in vivo will reveal new targets for optimizing the directed expansion and/or differentiation of adult-type HSCs for clinical use.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Activation of the Inflammasome Controls Hematopoietic Stem Cell Production
  • 批准号:
    10668397
  • 项目类别:
  • 资助金额:
    $52.38万
  • 财政年份:
    2020
  • 负责人:
    TRISTA E. NORTH
  • 依托单位:
Developmental Activation of the Inflammasome Controls Hematopoietic Stem Cell Production
  • 批准号:
    10213134
  • 项目类别:
  • 资助金额:
    $54.48万
  • 财政年份:
    2020
  • 负责人:
    TRISTA E. NORTH
  • 依托单位:
Developmental Activation of the Inflammasome Controls Hematopoietic Stem Cell Production
  • 批准号:
    10453669
  • 项目类别:
  • 资助金额:
    $53.08万
  • 财政年份:
    2020
  • 负责人:
    TRISTA E. NORTH
  • 依托单位:
Biomechanical Activation of Yap Induces Hematopoietic Stem Cell Production
  • 批准号:
    10377442
  • 项目类别:
  • 资助金额:
    $54.34万
  • 财政年份:
    2020
  • 负责人:
    TRISTA E. NORTH
  • 依托单位:
海外基金